|
1
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maher EJ and Denton A: Survivorship, late effects and cancer of the cervix. Clin Oncol (R Coll Radiol). 20:479–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Waggoner SE: Cervical cancer. Lancet. 361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arbyn M, Tommasino M, Depuydt C and Dillner J: Are 20 human papillomavirus types causing cervical cancer? J Pathol. 234:431–435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ibeanu OA: Molecular pathogenesis of cervical cancer. Cancer Biol Ther. 11:295–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arvanitis DA and Spandidos DA: Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: A case control study. Oncol Rep. 20:751–760. 2008.PubMed/NCBI
|
|
8
|
von Knebel Doeberitz M, Reuschenbach M, Schmidt D and Bergeron C: Biomarkers for cervical cancer screening: The role of p16(INK4a) to highlight transforming HPV infections. Expert Rev Proteomics. 9:149–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malumbres M and Barbacid M: To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer. 1:222–231. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gaillard H, García-Muse T and Aguilera A: Replication stress and cancer. Nat Rev Cancer. 15:276–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crozier L, Foy R, Mouery BL, Whitaker RH, Corno A, Spanos C, Ly T, Cook JG and Saurin AT: CDK4/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal. bioRxiv: 2021. doi.org/10.1101/2021.02.03.428245 (Preprint).
|
|
12
|
Spardy N, Covella K, Cha E, Hoskins EE, Wells SI, Duensing A and Duensing S: Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res. 69:7022–7029. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL and Chen W: p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: A 3-year cohort study in China. Oncotarget. 7:64810–64819. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reuschenbach M, Wentzensen N, Dijkstra MG, von Knebel Doeberitz M and Arbyn M: p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement. Am J Clin Pathol. 142:767–772. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim S, Lee MJ, Cho I, Hong R and Lim SC: Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group. Oncol Lett. 11:1447–1452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V and Paraskevaidis E: p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis. Cancer Treat Rev. 35:210–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gonçalves JES, de Andrade CV, Russomano FB, Nuovo G, Amaro-Filho SM, Carvalho MOO and Nicol AF: The role of p16 as putative biomarker for cervical neoplasia: A controversial issue? MedicalExpress. 4:M1706012017.
|
|
18
|
Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER and Cho KR: Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 67:10163–10172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, et al: Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, et al: Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67:4605–4619. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pappa KI, Polyzos A, Jacob-Hirsch J, Amariglio N, Vlachos GD, Loutradis D and Anagnou NP: Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells. PLoS One. 10:e01422292015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harding NJSH, How C, Saha S, Hui AB, Chong LC, Yan R, Fei-Fei Liu FF and Kasprzyk A: Identification and Correction of Amplification Protocol Bias in Microarray Studies, arrayexpress-repository. 2014. https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-42764/July 27–2020
|
|
23
|
Winder DM, Chattopadhyay A, Muralidhar B, Bauer J, English WR, Zhang X, Karagavriilidou K, Roberts I, Pett MR, Murphy G, et al: Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness. J Pathol. 225:448–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et al: Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Medina-Martinez I, Barrón V, Roman-Bassaure E, Juárez-Torres E, Guardado-Estrada M, Espinosa AM, Bermudez M, Fernández F, Venegas-Vega C, Orozco L, et al: Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: A genome-wide follow-up study. PLoS One. 9:e978422014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biewenga P, Buist MR, Moerland PD, Ver Loren van Themaat E, van Kampen AH, ten Kate FJ and Baas F: Gene expression in early stage cervical cancer. Gynecol Oncol. 108:520–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharma S, Mandal P, Sadhukhan T, Roy Chowdhury R, Ranjan Mondal N, Chakravarty B, Chatterjee T, Roy S and Sengupta S: Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis. Sci Rep. 5:117242015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Warbrick E, Coates PJ and Hall PA: Fen1 expression: A novel marker for cell proliferation. J Pathol. 186:319–324. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sharma S, Sommers JA, Gary RK, Friedrich-Heineken E, Hübscher U and Brosh RM Jr: The interaction site of Flap Endonuclease-1 with WRN helicase suggests a coordination of WRN and PCNA. Nucleic Acids Res. 33:6769–6781. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Becker JR, Gallo D, Leung W, Croissant T, Thu YM, Nguyen HD, Starr TK, Brown GW and Bielinsky AK: Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner. Nucleic Acids Res. 46:5634–5650. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh P, Yang M, Dai H, Yu D, Huang Q, Tan W, Kernstine KH, Lin D and Shen B: Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol Cancer Res. 6:1710–1717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiao X, Wu Y, Zhou L, He J, Yang C, Zhang P, Hu R, Luo C, Du J, Fu J, et al: Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: A population-based study in China. Sci Rep. 5:181602015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abdel-Fatah TMA, Russell R, Albarakati N, Maloney DJ, Dorjsuren D, Rueda OM, Moseley P, Mohan V, Sun H, Abbotts R, et al: Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Mol Oncol. 8:1326–1338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H, Sun H, Jiang F, Kathera CS, Liu L, et al: FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer. Mol Oncol. 11:640–654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nikolova T, Christmann M and Kaina B: FEN1 is overexpressed in testis, lung and brain tumors. Anticancer Res. 29:2453–2459. 2009.PubMed/NCBI
|
|
36
|
Urbanucci A, Sahu B, Seppälä J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lähdesmäki H, Jänne OA, et al: Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer. Oncogene. 31:2153–2163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu L, Zhou C, Zhou L, Peng L, Li D, Zhang X, Zhou M, Kuang P, Yuan Q, Song X, et al: Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis. 33:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y-D, Zhang X, Qiu X-G, Li J, Yuan Q, Jiang T and Yang M: Functional FEN1 genetic variants and haplotypes are associated with glioma risk. J Neurooncol. 111:145–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jia F, Chi C and Han M: Regulation of Nucleotide Metabolism and Germline Proliferation in Response to Nucleotide Imbalance and Genotoxic Stresses by EndoU Nuclease. Cell Rep. 30:1848–1861.e1845. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu C, Zhang Y, Shen Y, Shi Y, Zhang M and Zhou L: Integrated Analysis Reveals ENDOU as a Biomarker in Head and Neck Squamous Cell Carcinoma Progression. Front Oncol. 10:5223322021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Inaba N, Renk T, Daume E and Bohn H: Ectopic production of placenta-‘specific’ tissue proteins (PP5 and PP11) by malignant breast tumors. Arch Gynecol. 231:87–90. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Inaba N, Ishige H, Ijichi M, Satoh N, Ohkawa R, Sekiya S, Shirotake S, Takamizawa H, Renk T and Bohn H: Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas. Oncodev Biol Med. 3:379–389. 1982.PubMed/NCBI
|
|
43
|
Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, et al: Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 12:115–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gautier L, Cope L, Bolstad BM and Irizarry RA: affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Carvalho BS and Irizarry RA: A framework for oligonucleotide microarray preprocessing. Bioinformatics. 26:2363–2367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Du P, Kibbe WA and Lin SM: lumi: A pipeline for processing Illumina microarray. Bioinformatics. 24:1547–1548. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Prada C LD and Nakaya H: MetaVolcanoR: Gene Expression Meta-analysis Visualization Tool. R package version 1.3.0. 2020.https://www.bioconductor.org/packages/release/bioc/html/MetaVolcanoR.html
|
|
49
|
Viechtbauer W: Conducting Meta-Analyses in R with The metafor Package. Journal of Statistical Software. 36:1–48. 2010. View Article : Google Scholar
|
|
50
|
Harrison PF, Pattison AD, Powell DR and Beilharz TH: Topconfects: A package for confident effect sizes in differential expression analysis provides a more biologically useful ranked gene list. Genome Biol. 20:672019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xia J, Gill EE and Hancock RE: NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc. 10:823–844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Leek JT, Johnson WE, Parker HS, Jaffe AE and Storey JD: The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 28:882–883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Huang W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kulinskaya E and Dollinger MB: An accurate test for homogeneity of odds ratios based on Cochran's Q-statistic. BMC Med Res Methodol. 15:492015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Riley RD, Higgins JPT and Deeks JJ: Interpretation of random effects meta-analyses. BMJ. 342:d5492011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yu G, Wang L-G, Yan G-R and He Q-Y: DOSE: An R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 31:608–609. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
G Y: Enrichplot: Visualization of Functional Enrichment Result. R package version 1.8.1. 2020. https://bioconductor.org/packages/release/bioc/html/enrichplot.html
|
|
58
|
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47D:D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Feng G, Shaw P, Rosen ST, Lin SM and Kibbe WA: Using the bioconductor GeneAnswers package to interpret gene lists. Methods Mol Biol. 802:101–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hänzelmann S, Castelo R and Guinney J: GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cancer Genome Atlas Research NetworkAlbert Einstein College of MedicineAnalytical Biological ServicesBarretos Cancer HospitalBaylor College of MedicineBeckman Research Institute of City of HopeBuck Institute for Research on AgingCanada's Michael Smith Genome Sciences CentreHarvard Medical SchoolHelen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, et al, . Integrated genomic and molecular characterization of cervical cancer. Nature. 543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44:e71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Villanueva RAM and Chen ZJ: ggplot2: Elegant Graphics for Data Analysis (2nd ed.). Measurement: Interdisciplinary Res Perspectives. 17:160–167. 2019.
|
|
65
|
Babion I, Miok V, Jaspers A, Huseinovic A, Steenbergen RDM, van Wieringen WN and Wilting SM: Identification of Deregulated Pathways, Key Regulators, and Novel miRNA-mRNA Interactions in HPV-Mediated Transformation. Cancers (Basel). 12:7002020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Therneau TM and Terry M: A Package for Survival Analysis in R, 2020. https://CRAN.R-project.org/package=survival
|
|
67
|
Nagy Á, Munkácsy G and Győrffy B: Pancancer survival analysis of cancer hallmark genes. Sci Rep. 11:60472021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Altman DG and De Stavola BL: Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med. 13:301–341. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rosty C, Sheffer M, Tsafrir D, Stransky N, Tsafrir I, Peter M, de Crémoux P, de La Rochefordière A, Salmon R, Dorval T, et al: Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene. 24:7094–7104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kim I-S, Lee M-Y, Lee I-H, Shin S-L and Lee S-Y: Gene expression of flap endonuclease-1 during cell proliferation and differentiation. Biochim Biophys Acta. 1496:333–340. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang K, Keymeulen S, Nelson R, Tong TR, Yuan YC, Yun X, Liu Z, Lopez J, Raz DJ and Kim JY: Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer. Am J Pathol. 188:242–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Moody C: Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes. Viruses. 9:2612017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen J: Signaling pathways in HPV-associated cancers and therapeutic implications. Rev Med Virol. 25 (Suppl 1):24–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Egawa N, Wang Q, Griffin HM, Murakami I, Jackson D, Mahmood R and Doorbar J: HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions. PLoS Pathog. 13:e10062822017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wilhelm T, Olziersky A-M, Harry D, De Sousa F, Vassal H, Eskat A and Meraldi P: Mild replication stress causes chromosome mis-segregation via premature centriole disengagement. Nat Commun. 10:35852019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang J, Dai Q, Park D and Deng X: Targeting DNA Replication Stress for Cancer Therapy. Genes (Basel). 7:512016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bordignon V, Di Domenico EG, Trento E, D'Agosto G, Cavallo I, Pontone M, Pimpinelli F, Mariani L and Ensoli F: How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery. Viruses. 9:3902017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Katz MHG and Takabe K: High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers (Basel). 12:28712020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, Endo I and Takabe K: G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer. Int J Mol Sci. 21:29212020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Cerciello F, Hofstetter B, Fatah SA, Zaghloul M, Odermatt B, Bodis S, Varga Z, Pruschy M and Ciernik IF: G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int J Radiat Oncol Biol Phys. 62:1390–1398. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Poe JC, Kountikov EI, Lykken JM, Natarajan A, Marchuk DA and Tedder TF: EndoU is a novel regulator of AICD during peripheral B cell selection. J Exp Med. 211:57–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Qi W, Gromoff EDV, Xu F, Zhao Q, Yang W, Pfeifer D, Maier W, Long L and Baumeister R: The secreted endoribonuclease ENDU-2 from the soma protects germline immortality in C. elegans. Nat Commun. 12:12622021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Perl K, Ushakov K, Pozniak Y, Yizhar-Barnea O, Bhonker Y, Shivatzki S, Geiger T, Avraham KB and Shamir R: Reduced changes in protein compared to mRNA levels across non-proliferating tissues. BMC Genomics. 18:3052017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kotake Y, Naemura M, Murasaki C, Inoue Y and Okamoto H: Transcriptional Regulation of the p16 Tumor Suppressor Gene. Anticancer Res. 35:4397–4401. 2015.PubMed/NCBI
|
|
85
|
Hasan S, Stucki M, Hassa PO, Imhof R, Gehrig P, Hunziker P, Hübscher U and Hottiger MO: Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300. Mol Cell. 7:1221–1231. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Uxa S, Castillo-Binder P, Kohler R, Stangner K, Müller GA and Engeland K: Ki-67 gene expression. Cell Death Differ. 1–14. 2021.PubMed/NCBI
|
